4 The Guideline Development Group, Guideline‑producing team members, NICE project team, and declarations of interests

4 The Guideline Development Group, Guideline‑producing team members, NICE project team, and declarations of interests

4.1 Guideline Development Group

Weeliat Chong
Chief Pharmacist, Humber NHS Foundation Trust

Stephen Dean
Consultant in Intensive Care and Anaesthesia, Leeds Teaching Hospital NHS Trust

David Erskine
Director of London and South East Regional Medicines Information Service, Guy's and St Thomas' NHS Foundation Trust

Leslie Galloway (until end May 2014)
Chairman, Ethical Medicines Industry Group (EMIG)

Brian Hawkins
Chief Pharmacist, Cwm Taf Local Health Board

John Holden
General Practitioner, Garswood Surgery, St Helens

Tessa Lewis
General Practitioner and Medical Advisor in therapeutics

Harriet Lewis
Regional Partnership Manager, Association of the British Pharmaceutical Industry (ABPI)

Margaret Ogden
Lay member

Bunis Packham
Nurse Consultant Thrombosis and Anticoagulation, Royal Free London NHS Foundation Trust

Richard Seal
Chief Pharmacist and Clinical Lead for Medicines Optimisation, NHS Trust Development Authority

David Terry
Director, Pharmacy Practice Unit, Birmingham Children's Hospital

Katrina Vout
Medicines Management Development Manager, Northern, Eastern and Western Devon Clinical Commissioning Group

Mary Weatherstone
Specialist Pharmacist and Practice Pharmacist, Norfolk and Waveney Clinical Commissioning Groups and Coastal Partnership Practice

Nigel Westwood
Lay member

4.2 Guideline-producing team members

NICE Medicines and Prescribing Centre

Johanna Hulme
Associate director

Shelly Patel
Senior Adviser

Louise Picton
Senior Adviser

Ian Pye
Assistant Project Manager

York Health Economics Consortium Ltd

Michelle Jenks
Research consultant

James Mahon
Senior associate

4.3 NICE project team

Christine Carson
Guideline Lead

Mark Baker
Clinical Adviser

Clifford Middleton, Caroline Keir
Guideline Commissioning Manager

Rebecca Pye (until February 2015), Margaret Ghlaimi (from February 2015)
Guideline Coordinator

Judith Thornton
Technical Lead

Bhash Naidoo
Health Economist

Annette Mead
Editor

4.4 Acknowledgements

The Guideline Development Group would like to thank Sue Faulding, Rita Faria, David Gerrett, Jasdeep Hayre and Neal Maskrey for their contribution to the development of the guideline.

4.5 Declarations of interests

The following members of the Guideline Development Group made declarations of interests. All other members of the Group stated that they had no interests to declare.

Member

Interest declared

Type of interest

Decision taken

Leslie Galloway (until end May 2014)

Presents to members of EMIG and will be asked about medicines optimisation.

Specific personal non‑pecuniary

Advice given regarding speaking about medicines optimisation. He stated he will not answer questions directly relating to medicines optimisation while on the GDG

Brian Hawkins

Presentation at training event for MSD staff – May 2011.

Non‑specific personal non‑pecuniary

Declare and participate

Brian Hawkins

Presentation at training event for Lilly staff – June 2011.

Non‑specific personal non‑pecuniary

Declare and participate

Brian Hawkins

Employer, Cwm Taf LHB, has received funding for project from TEVA UK Ltd and GSK.

Non‑specific non‑personal pecuniary

Declare and participate

Brian Hawkins

Asked to be a speaker at the hospital pharmacy Europe conference in Birmingham on 9 September 2014 on the subject of 'Optimising medicines management'.

Specific personal non‑pecuniary

Advised he needs to be very careful of the content of the presentation and not discuss the guideline

Tessa Lewis

Wrote an article on medication review.

Specific personal non‑pecuniary

Declare and participate

Harriet Lewis

Employee of Association of British Pharmaceutical Industry (ABPI).

Non‑specific personal pecuniary

Declare and participate

Margaret Ogden

Sits on a voluntary patient advisory group with a pharmaceutical company.

Attended a one‑to‑one meeting with a small pharmaceutical company.

Non‑specific personal non‑pecuniary

Advised not to discuss the guideline

Margaret Ogden

Working with Alzheimer's Society on patient reported outcomes.

Non‑specific personal non‑pecuniary

Declare and participate

Margaret Ogden

Attending a medication safety focus group on 11 July for NIHR Greater Manchester Primary Care Patient Safety Translational Research Centre.

Non‑specific personal non‑pecuniary

Declare and participate

Bunis Packham

Previous work involved medicines adherence.

Non‑specific personal non‑pecuniary

Declare and participate

Richard Seal

Wife is a practice support pharmacist employed by Arden Commissioning Support Unit and also employed as a practice pharmacist by a GP practice.

Non‑specific personal pecuniary

Advised to be careful when discussing medicines optimisation and to not discuss the guideline

Richard Seal

Provides advisory support for pharmaceutical journal for which he receives no recompense.

Non‑specific personal non‑pecuniary

Richard Seal

Spoken on medicine optimisation at the Pharmacy Management National Seminar.

Specific personal non‑pecuniary

Richard Seal

Notified the GDG that he is no longer a member of Pharmacy Management.

NA

Declare and participate

David Terry

Presenting at a conference in March 2014.

Non‑specific personal non‑pecuniary

Advised not to discuss the guideline and be careful of presentation content

David Terry

Co‑ownership of NuCo R&D Ltd. NuCo was incorporated as a company on 26 February 2014. It is a research company but may in the future also distribute and or sell medicines. At present does not believe there is anything on NuCo's agenda/portfolio that causes concern with this guideline. NuCo is not currently trading.

Non‑specific personal pecuniary

Declare and participate

David Terry

Accepted an invitation to take part in The Clinical Pharmacy Congress 2014, 25–26 April 2014. He joined a panel, sponsored by Sanofi‑Aventis to discuss the subject: The wider role of pharmacists in delivering outcomes in diabetes.

Non‑specific personal non‑pecuniary

Declare and participate

Mary Weatherstone

Member of an NHS England clinical reference group on Medicines Optimisation.

Specific personal non‑pecuniary

Advised not to discuss the guideline at the reference group

Mary Weatherstone

Is a NICE MPC Associate.

Specific personal non‑pecuniary

Declare and participate

Nigel Westwood

Received travel expenses and attendance fees from a number of pharmaceutical companies when attending meetings (Abbott, Proctor and Gamble, Kinetic Concepts Inc., UCB and Warner Chillcott) as a speaker on patient experience to pharmaceutical staff, trainee medical professionals and specialist registrars.

Non‑specific personal pecuniary

Advised not to discuss the guideline.

  • National Institute for Health and Care Excellence (NICE)